RIS participates in SARC Conference in Chicago

Dr Scott Okuno moderates Clinical Trial Reports at 2016 SARC Conference

Dr Scott Okuno moderates Clinical Trial Reports at 2016 SARC Conference

For the first time Rein in Sarcoma leadership joined over 300 sarcoma doctors and researchers from throughout country on June 3rd in attending the SARC (Sarcoma Alliance for Research through Collaboration) semiannual conferee in Chicago.

SARC is a non-profit organization dedicated to the development and support of research for the prevention, treatment, and cure of sarcomas – a cancer of the bone and connective tissue of the body.

SARC”s mission is to provide a collaborative infrastructure to make progress in the prevention, diagnosis and treatment of sarcoma. Dr. Scott Okuno from the Mayo Clinic serves as the Chief Medical Officer of SARC. In Minnesota there are three SARC Center Locations: Children’s Hospitals and Clinics, Mayo Clinic and the University of Minnesota.

Sue and Pete Wyckoff attended this pivotal conference on behalf of RIS. The meeting started with three symposium Speakers whose theme was the liquid biopsy. Specific topics were: Astrocyte-derived Exosomal mircoRNA primes in brain metastasis outgrowth, exomes as markers for Kaposi Sarcoma Progression, Circulating Tumor DNA.

We then heard presentations by the chief investigators of seven sarcoma clinical trials in a session moderated by Dr. Okuno. The results have been mixed. Some trials have been discontinued and some are moving forward. As sarcoma advocates, the exciting part of the meeting was being in a room with so many scientists who are so passionate about finding cures for sarcoma. The energy in the room was amazing; the questions that were being explored back and forth seem to indicate that several new ways of attacking sarcoma are being explored vigorously. All of this scientific activity brings new hope to current and future patients.